PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2052
https://www.valueinhealthjournal.com/article/S1098-3015(12)03765-5/fulltext
Title :
PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03765-5&doi=10.1016/j.jval.2012.08.2052
First page :
A569
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
1538